Oxygen dosing during surgery may reduce lung complications

NCT ID NCT06013098

Completed Disease control Sponsor: China Medical University, China Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether using different oxygen concentrations during and after esophageal cancer surgery could lower the risk of lung collapse (atelectasis). 65 patients were randomly assigned to receive either 30% or 60% oxygen during two-lung ventilation. The main goal was to see how often lung collapse occurred after surgery, measured by CT scan. The results could help guide oxygen use in the operating room.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: oxygen
What this could lead to: If successful, this could help doctors choose the best oxygen levels during surgery to reduce lung problems after esophageal cancer removal.
What could go wrong: This is a small, completed Phase 4 trial with only 65 participants. Results may not apply to all patients or surgeries, and the benefit may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATELECTASIS, POSTOPERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer Pulmonary Atelectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATELECTASIS, POSTOPERATIVE

Contacts and locations

Locations

the First Hospital of China Medical University

Shenyang, Liaoning, 110001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.